Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.180
+0.095 (2.33%)
Jun 10, 2026, 3:25 PM EDT - Market open
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $99.45 million as of June 10, 2026. Its market cap has increased by 90.59% in one year.
Market Cap
99.45M
Enterprise Value
-6.86M
1-Year Change
90.59%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $99.45M, a decrease of -53.64%. That is a compound annual growth rate of -46.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 97.19M | -38.43% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 107.66M |
| Verrica Pharmaceuticals | 103.76M |
| Coya Therapeutics | 103.68M |
| Cardiff Oncology | 102.55M |
| Vivani Medical | 101.76M |
| Seer, Inc. | 98.42M |
| Cibus | 98.41M |
| Aldeyra Therapeutics | 98.32M |